Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 24, 2025 • 11:31 PM ET
As of June 24, 2025 • 11:31 PM ET
Date/Time | Source | News Release |
---|---|---|
06/11/2025 01:26 PM EDT | SeekingAlpha | AbbVie wins FDA nod for a label expansion of Enanta-partnered antiviral |
06/10/2025 09:54 PM EDT | Stock Traders Daily | (ENTA) Proactive Strategies |
05/19/2025 01:26 AM EDT | Stock Traders Daily | (ENTA) On The My Stocks Page |
05/15/2025 09:55 AM EDT | Zacks | Does Enanta Pharmaceuticals (ENTA) Have the Potential to Rally 189.58% as Wall Street Analysts Expect? |
05/12/2025 05:10 PM EDT | Zacks | Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates |
05/12/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, May 12th, 2025 |
05/12/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - Enanta Pharmaceuticals Inc. |
05/11/2025 06:48 PM EDT | KlickAnalytics | ENTA - Historical Price Movements Surrounding Earnings |
05/11/2025 06:43 PM EDT | KlickAnalytics | ENTA - Historical Earnings Price Analysis |
05/08/2025 06:20 PM EDT | Zacks | Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.